Sarepta Therapeutics (SRPT) Debt Ratio (2010 - 2026)

Sarepta Therapeutics' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.26 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 19.73% year-over-year to 0.26 in Q1 2026; TTM through Mar 2026 was 0.26, a 19.73% decrease from a year earlier, with the FY2025 full-year figure at 0.25, down 13.75% from the prior year.
• Debt Ratio climbed to 0.26 in Q1 2026 per SRPT's latest filing, from 0.25 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.49 in Q4 2022 and bottomed at 0.25 in Q4 2025.
• The 5-year median for Debt Ratio is 0.37 (2022), against an average of 0.36.
• Across the five-year window, Debt Ratio surged 175.69% in 2022 and plunged 30.28% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.49 in 2022, then fell by 16.63% to 0.41 in 2023, then tumbled by 30.28% to 0.29 in 2024, then dropped by 13.75% to 0.25 in 2025, then climbed by 6.54% to 0.26 in 2026.
• Per Business Quant, the three latest SRPT Debt Ratio figures stand at 0.26 (Q1 2026), 0.25 (Q4 2025), and 0.31 (Q3 2025).